Shenzhen Capital Group, CCB International, CICC and China Merchants Securities Investment led a $200m fundraising round in OrbusNeich, a medical device manufacturer. “OrbusNeich is uniquely positioned to take advantage of the explosive growth in new healthcare technologies in cardiovascular and peripheral intervention. Backed by our new investors as valued partners, we are confident that we will be able to bring innovations to our customers worldwide by leveraging our dedicated and specialised research team, first-class production facilities and established distribution network, thereby bringing the most suitable and best quality products to cater for patients’ needs,” David Chien, OrbusNeich CEO.